ID

31053

Description

Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00707304

Link

https://clinicaltrials.gov/show/NCT00707304

Keywords

Versions (1)
  1. 7/14/18 7/14/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 14, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non Small Cell Lung Cancer NCT00707304

English

Eligibility Non Small Cell Lung Cancer NCT00707304

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed stage iiib or iv nsclc
Description

Non-Small Cell Lung Carcinoma TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
failed at least 2 prior systemic anti-cancer regimens for advanced or metastatic nsclc
Description

Cancer treatment Systemic Quantity failed | Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer metastatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0231175
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C0205179
UMLS CUI [3]
C0278987
at least one target lesion that is unirradiated and measurable by recist
Description

Target Lesion Quantity Without Irradiation | Target Lesion Measurable Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C2986546
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0332288
UMLS CUI [1,4]
C1522449
UMLS CUI [2,1]
C2986546
UMLS CUI [2,2]
C1513040
UMLS CUI [2,3]
C1265611
adequate hematologic, renal and hepatic function
Description

Hematologic function | Renal function | Liver function

Data type

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
ecog 0, 1, or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
able to understand and sign an informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of brain metastases, unless the patient received brain irradiation, including adequate stereotactic radiosurgery, at least 4 weeks prior to randomization, and is stable, asymptomatic, and off steroids for at least 3 weeks prior to randomization
Description

Metastatic malignant neoplasm to brain | Exception Irradiation of whole brain | Exception Stereotactic Radiosurgery | Exception Patient's condition stable | Exception Patient Asymptomatic | Exception Steroids Discontinued

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C2064932
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C3846112
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1282982
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0030705
UMLS CUI [5,3]
C0231221
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0038317
UMLS CUI [6,3]
C1444662
any gastrointestinal tract disease or other medical condition resulting in the inability to take oral medications
Description

Gastrointestinal Disease | Other medical condition | Lacking Able to swallow Oral medication

Data type

boolean

Alias
UMLS CUI [1]
C0017178
UMLS CUI [2]
C3843040
UMLS CUI [3,1]
C0332268
UMLS CUI [3,2]
C2712086
UMLS CUI [3,3]
C0175795
history of other malignancies except: (i) adequately treated basal or squamous cell carcinoma of the skin; (ii) curatively treated, a) in situ carcinoma of the uterine cervix, b) prostate cancer, or c) superficial bladder cancer; or (iii) other curatively treated solid tumor with no evidence of disease for ≥ 5 years
Description

Cancer Other | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Curative treatment Carcinoma in situ of uterine cervix | Exception Curative treatment Prostate carcinoma | Exception Curative treatment Superficial carcinoma of urinary bladder | Exception Curative treatment Solid Neoplasm | Exception Disease Free of

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1273390
UMLS CUI [4,3]
C0851140
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1273390
UMLS CUI [5,3]
C0600139
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C1273390
UMLS CUI [6,3]
C1336527
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C1273390
UMLS CUI [7,3]
C0280100
UMLS CUI [8,1]
C1705847
UMLS CUI [8,2]
C0012634
UMLS CUI [8,3]
C0332296
uncontrolled ischemic heart disease, or uncontrolled symptomatic congestive heart failure
Description

Myocardial Ischemia Uncontrolled | Symptomatic congestive heart failure Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0151744
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0742758
UMLS CUI [2,2]
C0205318
serious active infection
Description

Communicable Disease Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
psychiatric illness/ social situations that would limit study compliance
Description

Mental disorders Protocol Compliance Limited | Social situation Protocol Compliance Limited

Data type

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0525058
UMLS CUI [1,3]
C0439801
UMLS CUI [2,1]
C0748872
UMLS CUI [2,2]
C0525058
UMLS CUI [2,3]
C0439801
other uncontrolled serious chronic disease or conditions that in the investigator's opinion could affect compliance or follow-up in the protocol
Description

Chronic disease Serious Uncontrolled | Condition Affecting Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0205318
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0525058
concurrent radiotherapy to any site or radiotherapy within 4 weeks prior to randomization or previous radiotherapy to the target lesion sites (the sites that are to be followed for determination of a response)
Description

Therapeutic radiology procedure Site Any | Therapeutic radiology procedure Recent | Prior radiation therapy Target Lesion Site

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1515974
UMLS CUI [1,3]
C1552551
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0332185
UMLS CUI [3,1]
C0279134
UMLS CUI [3,2]
C2986546
UMLS CUI [3,3]
C1515974
known hiv positive or on active anti-retroviral therapy
Description

HIV Seropositivity | Antiretroviral therapy

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C1963724
known hepatitis b surface antigen positive or hepatitis c positive
Description

Hepatitis B surface antigen positive | Hepatitis C positive

Data type

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C1112419
receipt of any investigational medication within 4 weeks prior to randomization
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
pregnant or lactating patients, or fertile female patients with a positive pregnancy test, or fertile female patients unwilling to use adequate contraception during treatment and 30 days after completion of treatment
Description

Pregnancy | Breast Feeding | Childbearing Potential Pregnancy test positive | Childbearing Potential Contraceptive methods Unwilling

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0240802
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0700589
UMLS CUI [4,3]
C0558080
sexually active male patients unwilling to practice contraception while participating on the study and up to 30 days after completion of treatment
Description

Gender Sexually active | Contraceptive methods Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0241028
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0558080
legal incapacity or limited legal capacity, unless authorization is granted by a legal guardian
Description

Legal capacity Lacking | Legal capacity Limited | Exception Authorization Legal Guardians

Data type

boolean

Alias
UMLS CUI [1,1]
C0683673
UMLS CUI [1,2]
C0332268
UMLS CUI [2,1]
C0683673
UMLS CUI [2,2]
C0439801
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0680281
UMLS CUI [3,3]
C0023226
Back to the top of the page

Similar models

Eligibility Non Small Cell Lung Cancer NCT00707304

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma TNM clinical staging
Item
histologically or cytologically confirmed stage iiib or iv nsclc
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Cancer treatment Systemic Quantity failed | Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer metastatic
Item
failed at least 2 prior systemic anti-cancer regimens for advanced or metastatic nsclc
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C0007131 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C0278987 (UMLS CUI [3])
Target Lesion Quantity Without Irradiation | Target Lesion Measurable Quantity
Item
at least one target lesion that is unirradiated and measurable by recist
boolean
C2986546 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0332288 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C2986546 (UMLS CUI [2,1])
C1513040 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Hematologic function | Renal function | Liver function
Item
adequate hematologic, renal and hepatic function
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
ECOG performance status
Item
ecog 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
able to understand and sign an informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Metastatic malignant neoplasm to brain | Exception Irradiation of whole brain | Exception Stereotactic Radiosurgery | Exception Patient's condition stable | Exception Patient Asymptomatic | Exception Steroids Discontinued
Item
presence of brain metastases, unless the patient received brain irradiation, including adequate stereotactic radiosurgery, at least 4 weeks prior to randomization, and is stable, asymptomatic, and off steroids for at least 3 weeks prior to randomization
boolean
C0220650 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C2064932 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C3846112 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1282982 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0030705 (UMLS CUI [5,2])
C0231221 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0038317 (UMLS CUI [6,2])
C1444662 (UMLS CUI [6,3])
Gastrointestinal Disease | Other medical condition | Lacking Able to swallow Oral medication
Item
any gastrointestinal tract disease or other medical condition resulting in the inability to take oral medications
boolean
C0017178 (UMLS CUI [1])
C3843040 (UMLS CUI [2])
C0332268 (UMLS CUI [3,1])
C2712086 (UMLS CUI [3,2])
C0175795 (UMLS CUI [3,3])
Cancer Other | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Curative treatment Carcinoma in situ of uterine cervix | Exception Curative treatment Prostate carcinoma | Exception Curative treatment Superficial carcinoma of urinary bladder | Exception Curative treatment Solid Neoplasm | Exception Disease Free of
Item
history of other malignancies except: (i) adequately treated basal or squamous cell carcinoma of the skin; (ii) curatively treated, a) in situ carcinoma of the uterine cervix, b) prostate cancer, or c) superficial bladder cancer; or (iii) other curatively treated solid tumor with no evidence of disease for ≥ 5 years
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
C0851140 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C1273390 (UMLS CUI [5,2])
C0600139 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C1273390 (UMLS CUI [6,2])
C1336527 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C1273390 (UMLS CUI [7,2])
C0280100 (UMLS CUI [7,3])
C1705847 (UMLS CUI [8,1])
C0012634 (UMLS CUI [8,2])
C0332296 (UMLS CUI [8,3])
Myocardial Ischemia Uncontrolled | Symptomatic congestive heart failure Uncontrolled
Item
uncontrolled ischemic heart disease, or uncontrolled symptomatic congestive heart failure
boolean
C0151744 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0742758 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Communicable Disease Serious
Item
serious active infection
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Mental disorders Protocol Compliance Limited | Social situation Protocol Compliance Limited
Item
psychiatric illness/ social situations that would limit study compliance
boolean
C0004936 (UMLS CUI [1,1])
C0525058 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0748872 (UMLS CUI [2,1])
C0525058 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
Chronic disease Serious Uncontrolled | Condition Affecting Protocol Compliance
Item
other uncontrolled serious chronic disease or conditions that in the investigator's opinion could affect compliance or follow-up in the protocol
boolean
C0008679 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
Therapeutic radiology procedure Site Any | Therapeutic radiology procedure Recent | Prior radiation therapy Target Lesion Site
Item
concurrent radiotherapy to any site or radiotherapy within 4 weeks prior to randomization or previous radiotherapy to the target lesion sites (the sites that are to be followed for determination of a response)
boolean
C1522449 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C0279134 (UMLS CUI [3,1])
C2986546 (UMLS CUI [3,2])
C1515974 (UMLS CUI [3,3])
HIV Seropositivity | Antiretroviral therapy
Item
known hiv positive or on active anti-retroviral therapy
boolean
C0019699 (UMLS CUI [1])
C1963724 (UMLS CUI [2])
Hepatitis B surface antigen positive | Hepatitis C positive
Item
known hepatitis b surface antigen positive or hepatitis c positive
boolean
C0149709 (UMLS CUI [1])
C1112419 (UMLS CUI [2])
Investigational New Drugs
Item
receipt of any investigational medication within 4 weeks prior to randomization
boolean
C0013230 (UMLS CUI [1])
Pregnancy | Breast Feeding | Childbearing Potential Pregnancy test positive | Childbearing Potential Contraceptive methods Unwilling
Item
pregnant or lactating patients, or fertile female patients with a positive pregnancy test, or fertile female patients unwilling to use adequate contraception during treatment and 30 days after completion of treatment
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0240802 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])
Gender Sexually active | Contraceptive methods Unwilling
Item
sexually active male patients unwilling to practice contraception while participating on the study and up to 30 days after completion of treatment
boolean
C0079399 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Legal capacity Lacking | Legal capacity Limited | Exception Authorization Legal Guardians
Item
legal incapacity or limited legal capacity, unless authorization is granted by a legal guardian
boolean
C0683673 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
C0683673 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0680281 (UMLS CUI [3,2])
C0023226 (UMLS CUI [3,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial